Physical

U.S. Food and Drug Administration Grants Cabaletta Bio Fast Track Designation for MuSK-CAART

Retrieved on: 
Tuesday, March 1, 2022

PHILADELPHIA, March 01, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for patients with autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for MuSK-CAART, or muscle-specific kinase (MuSK) chimeric autoantibody receptor T (MuSK-CAART) cells, to improve activities of daily living and muscle strength in patients with MuSK antibody-positive myasthenia gravis. MuSK-CAART is being evaluated as a potential treatment for patients with MuSK-associated myasthenia gravis (MG).

Key Points: 
  • Cabalettas Investigational New Drug (IND) application was recently cleared by the FDA within the routine 30-day review period.
  • Cabaletta plans to initiate a first-in-human clinical trial in 2022 for MuSK-CAART.
  • Cabaletta Bios headquarters are located in Philadelphia, PA. For more information, visit www.cabalettabio.com and follow us on LinkedIn.
  • All information in this press release is as of the date of the release, and Cabaletta undertakes no duty to update this information unless required by law.

Lacerta Therapeutics Expands Executive Leadership Team

Retrieved on: 
Tuesday, March 1, 2022

Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: Kenneth Warrington, Jr., PhD, co-founder of Lacerta, has joined as the companys Chief Technology Officer (CTO), and Darin Falk, PhD, former Vice President of Gene Therapy Programs at Lacerta, will now serve as the companys Chief Scientific Officer (CSO).

Key Points: 
  • Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: Kenneth Warrington, Jr., PhD, co-founder of Lacerta, has joined as the companys Chief Technology Officer (CTO), and Darin Falk, PhD, former Vice President of Gene Therapy Programs at Lacerta, will now serve as the companys Chief Scientific Officer (CSO).
  • Both Warrington and Falk represent significant additions to CEO Edgar Rodriguez-Lebrons executive team, and further illustrate Lacertas commitment to developing a constellation of gene-based therapies.
  • Lacerta has an outstanding team with extensive expertise and is well-equipped to deliver novel therapeutic options for patient success, said Dr. Falk.
  • Lacerta Therapeutics, Inc. is focused on exploiting our proprietary capsid technology and scalable manufacturing platform to advance AAV-based therapies via three primary approaches: gene replacement, gene modulation and novel vectorization of antibodies.

Sectigo Announces Digital Accessibility Enhancements to Sectigo Certificate Manager

Retrieved on: 
Thursday, February 24, 2022

Roseland, NJ, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Sectigo , a global leader in digital certificates and automated Certificate Lifecycle Management (CLM), today announced accessibility updates to its flagship product Sectigo Certificate Manager (SCM) that meet global compliance guidelines.

Key Points: 
  • Roseland, NJ, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Sectigo , a global leader in digital certificates and automated Certificate Lifecycle Management (CLM), today announced accessibility updates to its flagship product Sectigo Certificate Manager (SCM) that meet global compliance guidelines.
  • We are pleased to be able to offer this new accessibility tool to better accommodate all our unique users.
  • Sectigo is a leading provider of digital certificates and automated Certificate Lifecycle Management (CLM) solutions - trusted by the worlds largest brands.
  • Its cloud-based universal CLM platform issues and manages the lifecycles of digital certificates issued by Sectigo and other Certificate Authorities (CAs) to secure every human and machine identity across the enterprise.

Nearly $15 Million in Grants Accessed by M&T Bank through the Federal Home Loan Bank of New York for Affordable Housing Projects

Retrieved on: 
Tuesday, February 22, 2022

The grants are provided through the Federal Home Loan Bank of New York (FHLBNY) Affordable Housing Program, of which M&T is a member.

Key Points: 
  • The grants are provided through the Federal Home Loan Bank of New York (FHLBNY) Affordable Housing Program, of which M&T is a member.
  • St. Bernard's Housing Development Fund Co., Inc. received $1 million for the rehabilitation and preservation of 160 senior housing units at St. Bernard's Park in Rochester.
  • $809,455 was awarded to Troy Housing Authority for the redevelopment of the 85-unit Taylor Apartments project in Troy.
  • Michaels Development was granted $2.2 million for the construction of 111 new units at Saddle River Family in Saddler River.

YourSix Launches ZINFI Partner Portal to Increase Engagement with Reseller Partners, Automate Partner Onboarding Process

Retrieved on: 
Tuesday, February 22, 2022

Since launching in February 2021, YourSix has onboarded more than 150 partners through the partner portal.

Key Points: 
  • Since launching in February 2021, YourSix has onboarded more than 150 partners through the partner portal.
  • "For technology companies selling to multiple verticals through a distributed channel, managing relationships with partner resellers can be very complex," said Sugata Sanyal, founder and CEO of ZINFI.
  • To learn more about how YourSix is using the ZINFI partner portal to deepen their partners' knowledge about YourSix solutions and help them sell more effectively, please click here .
  • You can also follow ZINFI Technologies on LinkedIn and at the ZINFI Channel Marketing Best Practices blog .

CareAcademy Expands Home Health Training Library With State-Approved Continuing Education Courses for Occupational and Physical Therapists

Retrieved on: 
Thursday, February 17, 2022

CareAcademy , the leading care enablement platform for home care and home health organizations, today announced the release of 240+ hours of continuing education for state-licensed occupational and physical therapists.

Key Points: 
  • CareAcademy , the leading care enablement platform for home care and home health organizations, today announced the release of 240+ hours of continuing education for state-licensed occupational and physical therapists.
  • Home health nurses, as well as occupational and physical therapists, are frequently on their own to find CEUs to maintain licensure.
  • CareAcademys comprehensive home health training solution includes initial training and certification for home health aides, continuing education for nurses, occupational therapists, physical therapists and administrators, and advanced disease-specific certifications for ongoing specialization across the home health industry.
  • CareAcademy provides high-quality, state-approved training for home care agencies, home health agencies, franchise systems and payors that increases learner knowledge for better health outcomes.

Dylan Bates Joins Golden Bear as Lead Independent Board Director

Retrieved on: 
Tuesday, February 15, 2022

MODESTO, Calif., Feb. 15, 2022 /PRNewswire-PRWeb/ --Golden Bear Therapy Partners, a leading provider of outpatient physical therapy and rehabilitation services, announced today the addition of renowned industry veteran Dylan Bates as Lead Independent Board Director.

Key Points: 
  • MODESTO, Calif., Feb. 15, 2022 /PRNewswire-PRWeb/ --Golden Bear Therapy Partners, a leading provider of outpatient physical therapy and rehabilitation services, announced today the addition of renowned industry veteran Dylan Bates as Lead Independent Board Director.
  • Mr. Bates brings a wealth of industry knowledge and executive leadership experience to Golden Bear.
  • Most recently, Mr. Bates has served as a board member for several businesses including Southern Vet Partners (a Shore Capital Partners animal hospital platform.
  • Formed in 2019, Golden Bear Therapy Partners is a Physical Therapist led, a portfolio company of Shore Capital Partners.

CFPDP Celebrates Diversity Leadership on Canadian Corporate Boards and Paralympic Medal Winners Receive Award, Funding at 38th Annual Great Valentine Gala

Retrieved on: 
Thursday, February 10, 2022

At the 38th Annual Great Valentine Gala, being held virtually from Toronto on Feb. 12, 2022, CFPDP will celebrate two Canadian companies that each have a highly qualified person with a disability on their Boards of Directors: American Express Canada and OpenText.

Key Points: 
  • At the 38th Annual Great Valentine Gala, being held virtually from Toronto on Feb. 12, 2022, CFPDP will celebrate two Canadian companies that each have a highly qualified person with a disability on their Boards of Directors: American Express Canada and OpenText.
  • Additionally, Canadas 16 medal-winning athletes from the Tokyo Paralympic Games are being honoured during the 38th Annual Great Valentine Gala.
  • The 38th Annual Great Valentine Gala is presented by Scotiabank along with Platinum sponsor Deloitte.
  • The 38th Annual Great Valentine Gala will broadcast via YouTube on Sat., Feb. 12th at 7 p.m. virtualgala.cfpdp.com.

Dr. Aaron Barnard Strives to Better Treat Physical Therapy Patients Suffering from Unresolved Pain

Retrieved on: 
Friday, February 11, 2022

EUGENE, Ore., Feb. 11, 2022 /PRNewswire/ --Dr. Aaron Barnard, a Physical Therapist at Well Balanced Center for Integrated Care ,has received his certification in Cervical Revolution from the Postural Restoration Institute, striving to better treat his patients from unresolved pain!

Key Points: 
  • EUGENE, Ore., Feb. 11, 2022 /PRNewswire/ --Dr. Aaron Barnard, a Physical Therapist at Well Balanced Center for Integrated Care ,has received his certification in Cervical Revolution from the Postural Restoration Institute, striving to better treat his patients from unresolved pain!
  • While it may just feel like a tight neck, this causes the bones of the cranium and jaw to shift as well.
  • This can cause things like neck tension, facial asymmetry, limited jaw mobility, and can even change the way teeth touch.
  • Schedule an appointment with Dr. Barnard today if suffering from neck pain, jaw pain, migraines, vertigo, ringing in the ears, sinus congestion, or TMD!

DuraDerm SPORT and the UFC Performance Institute Announce Clinical Partnership

Retrieved on: 
Thursday, February 10, 2022

DuraDerm SPORT, a provider of a new, advanced liquid polymer has announced today an exciting partnership with the UFC Performance Institute, the worlds first Mixed Martial Arts (MMA) multi-disciplinary research, innovation, and training center.

Key Points: 
  • DuraDerm SPORT, a provider of a new, advanced liquid polymer has announced today an exciting partnership with the UFC Performance Institute, the worlds first Mixed Martial Arts (MMA) multi-disciplinary research, innovation, and training center.
  • DuraDerm SPORT will become the UFC Performance Institutes first-ever global Official Infection Prevention Partner, providing their athletes a cutting-edge alternative to traditional antibiotic-based treatments, which can decrease performance and develop resistance.
  • DuraDerm SPORT actively kills these dangerous pathogens on contact, and clinical trials have proven that it greatly reduces the risk of infection.
  • Clinically proven to prevent infection, DuraDerm SPORT is an important part of the UFC Performance Institutes skin treatment protocol vs. viruses, fungi and bacteria like staph and MRSA.